Literature DB >> 12190962

Interactions of human immunodeficiency virus-1 proteins with neurons: possible role in the development of human immunodeficiency virus-1-associated dementia.

M van de Bovenkamp1, H S L M Nottet, C F Pereira.   

Abstract

Human immunodeficiency virus-1 (HIV-1)-associated dementia is a severe neurological complication of HIV-1 infection that affects 15-20% of the patients in the late stages of acquired immunodeficiency syndrome. HIV-1-associated dementia is most probably a consequence of HIV-1 infection of the brain rather than of an opportunistic pathogen. The exact mechanism by which the virus causes this disorder, however, is not completely understood. A number of HIV-1 proteins have been shown to be released from HIV-1-infected cells and/or to be present in the extracellular milieu in the HIV-1-infected brain. Moreover, these proteins have been shown to possess neurotoxic and/or neuromodulatory features in vitro. This review describes the possible direct interactions of the HIV-1 proteins gp120, gp41, vpr, tat, rev, vpu and nef with neurons, which might play a role in the development of HIV-1-associated dementia in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12190962     DOI: 10.1046/j.1365-2362.2002.01029.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  31 in total

1.  Recent Insights into HIV Accessory Proteins.

Authors:  Jenny L. Anderson; Thomas J. Hope
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

2.  ER-β mediates 17β-estradiol attenuation of HIV-1 Tat-induced apoptotic signaling.

Authors:  Sheila M Adams; Marina V Aksenova; Michael Y Aksenov; Charles F Mactutus; Rosemarie M Booze
Journal:  Synapse       Date:  2010-11       Impact factor: 2.562

Review 3.  Neuropathogenesis of HIV-1-associated neurocognitive disorders: a possible involvement of D-serine.

Authors:  Jianxun Xia; Huangui Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-09-10

4.  Maturing neurons are selectively sensitive to human immunodeficiency virus type 1 exposure in differentiating human neuroepithelial progenitor cell cultures.

Authors:  Micheline McCarthy; Irving Vidaurre; Rebeca Geffin
Journal:  J Neurovirol       Date:  2006-10       Impact factor: 2.643

5.  MSM ameliorates HIV-1 Tat induced neuronal oxidative stress via rebalance of the glutathione cycle.

Authors:  Seol-Hee Kim; Adam J Smith; Jun Tan; R Douglas Shytle; Brian Giunta
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

6.  Increases in compulsivity, inflammation, and neural injury in HIV transgenic rats with escalated methamphetamine self-administration under extended-access conditions.

Authors:  Giordano de Guglielmo; Yu Fu; Jihuan Chen; Estefania Larrosa; Ivy Hoang; Tomoya Kawamura; Irene Lorrai; Barry Zorman; Joseph Bryant; Olivier George; Pavel Sumazin; Celine Lefebvre; Vez Repunte-Canonigo; Pietro Paolo Sanna
Journal:  Brain Res       Date:  2019-10-09       Impact factor: 3.252

7.  Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.

Authors:  Mahmoud L Soliman; Jonathan D Geiger; Xuesong Chen
Journal:  J Neuroimmune Pharmacol       Date:  2016-09-15       Impact factor: 4.147

8.  Attenuated neurotoxicity of the transactivation-defective HIV-1 Tat protein in hippocampal cell cultures.

Authors:  Michael Y Aksenov; Marina V Aksenova; Charles F Mactutus; Rosemarie M Booze
Journal:  Exp Neurol       Date:  2009-07-15       Impact factor: 5.330

Review 9.  Synaptic dysfunction in human immunodeficiency virus type-1-positive subjects: inflammation or impaired neuronal plasticity?

Authors:  V Avdoshina; A Bachis; I Mocchetti
Journal:  J Intern Med       Date:  2013-05       Impact factor: 8.989

10.  HIV-1 Antigens in Neurons of Cocaine-Abusing Patients.

Authors:  Milan Fiala; Elyse J Singer; Deborah Commins; Tamara Mirzapoiazova; Alexander Verin; Araceli Espinosa; Kenneth Ugen; Michael Bernas; Marlys Witte; Martin Weinand; Albert S Lossinsky
Journal:  Open Virol J       Date:  2008-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.